The pandemic of COVID-19 highlights the need for public health initiatives in ensuring population health. The spread of SARS-CoV-2 infections has been slowed by large-scale testing, contact tracing, social distancing, and mask usage. Precision medicine emphasizes more precise diagnosis and treatment based on a multiplicity of biomarkers, such as genetic variants, as well as data about the environment, lifestyle, and behaviors of patients. Individual vulnerability and responses to COVID-19 may be better understood using PM methods. PM methods, as they have proven for individuals taking medications like abacavir, may be useful for detecting risks of adverse treatment effects for patients with specific genetic variations, which can assist health-care providers decide whether to change dosages or avoid particular treatments for some people.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece